recombinant dengue antigens vaccine (sanofi-pasteur)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerecombinant dengue antigens vaccine (sanofi-pasteur)
Drug Alias Namedengue vaccine (Maxygen)Maxy-1500
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineBiologics > Protein drugs > Recombinant proteinVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsDengue
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMaxygen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMaxygenSanofi Pasteur Sa
Active IndicationsN/A
Inactive IndicationsDengue

Other Information

ATC CodeN/A
Related LinksN/A